hsa-mir-548l: Hsa-mir-548l is a significant miRNA that is common to both datasets [PMC8742548]. In a study, cell lines were transfected with hsa-mir-548l mimic or inhibitor, along with other miRNA mimics and inhibitors, and harvested 48 hours post-transfection [PMC9671919]. The expression of hsa-mir-548l was quantified and normalized to RNU6B using the Livak method [PMC9671919]. In another study, a tag SNP tagging a mature hsa-mir-548l variant was found among the SNPs located in miRNA genes [PMC4229095]. Hsa-mir-548l was also identified as one of the miRNAs affected by rare CNVs in CAKUT [PMC9587983]. Additionally, hsa-mir-548l was found to be involved in regulating genes associated with RASopathies [PMC6863982]. Heterozygous variants were identified in hsa-mir-548l in one patient [PMC6863982]. The rs13447640 variant is located in the 5' arm of hsa-mir-548l [PMC6863982]. Hsa-mir-548l was also associated with certain pathways according to TargetScan and IPA analysis [PMC5429229]. The rs1050955 polymorphism was predicted to be located near target binding sites for several miRNAs including hsa-miR-300, hsa-miR-381, and hsa-mir-548l according to bioinformatics tools [PMC3432110]. However, expression levels of hsa-miR-300, hasmiR381, haslet7f1*, haslet7a*, and hsal et7a* were low or absent compared to PAI1 and miR421 which were highly expressed [PMC3432110].